Clinical Social Workers in Barnardsville, NC Accepting Medicare
2 Clinical Social Workers found. Showing 1 - 2
 Whitney Hibbitts, PLCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 446 Poverty Branch Rd, Barnardsville, NC 28709 Phone: 828-450-0509 |
 Bruce Ullerup, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 14 Horseshoe Trail, Barnardsville, NC 28709 Phone: 828-253-0643 Fax: 828-225-2531 |
News Archive
FDA approves new radioactive drug for treatment of rare digestive tract cancers
The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Gene mutations that express LRRK2 linked to increased risk of Parkinson's disease: Researchers
A significant number of Parkinson's disease patients have a mutation of the enzyme Leucine-Rich Repeat Protein Kinase 2 (LRRK2, also known as dardarin). However, little is understood about how it is regulated or functions. In a new paper in the Signal Knowledge Environment of the Biochemical Journal, Dario Alessi and colleagues from the University of Dundee demonstrate that a family of proteins, the 14-3-3 proteins, interact with LRRK2.
State-mandated policy reduces opioid prescribing without impacting patient satisfaction, pain control
A state-mandated policy restricting opioid prescriptions along with increased public awareness and education about the opioid epidemic preceded drastic reductions in opioid prescribing and use for surgical patients at the University of Vermont Medical Center without impacting patient satisfaction with their postoperative pain management, according to findings presented at the American College of Surgeons Clinical Congress 2019.
Teen birth rate in the U.S. fell 2% between 2007 and 2008
The teen birth rate in the United States fell 2 percent between 2007 and 2008, after rising the previous two years, according to a report released today by the Centers for Disease Control and Prevention's National Center for Health Statistics.
Alkermes commences ALKS 37 phase 1 clinical trial for the treatment of opioid-induced constipation
Alkermes, Inc. today announced the initiation of a phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the opioid agonist effects on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC). The randomized, double-blind, placebo-controlled study will assess the safety, tolerability and pharmacokinetic effects of a single oral administration of five doses of ALKS 37 in approximately 40 healthy volunteers.
› Verified 9 days ago